Conestoga Discovery Investors holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Conestoga Discovery Fund Investors Class CMCMX
- NAV / 1-Day Return 10.21 / −0.87 %
- Total Assets 5.6M
-
Adj. Expense Ratio
1.500%
- Expense Ratio 1.500%
- Distribution Fee Level High
- Share Class Type No Load
- Category Small Growth
- Investment Style Small Growth
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 0.00
- Turnover 31%
USD | NAV as of Jul 18, 2026 | 1-Day Return as of Jul 18, 2026, 12:47 AM GMT+0
Morningstar’s Analysis CMCMX
Will CMCMX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 47.2
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Twist Bioscience Corp | 6.45 | 342,374 | Healthcare |
Electrovaya Inc | 5.62 | 298,446 | Industrials |
Digi International Inc | 4.81 | 255,176 | Technology |
Mama's Creations Inc Common Stock | 4.64 | 246,330 | Consumer Defensive |
Transcat Inc | 4.61 | 244,685 | Industrials |
CryoPort Inc | 4.54 | 240,826 | Industrials |
Vericel Corp | 4.27 | 226,444 | Healthcare |
BioLife Solutions Inc | 4.18 | 222,012 | Healthcare |
Palomar Holdings Inc | 4.07 | 215,793 | Financial Services |
The Vita Coco Co Inc | 4.03 | 213,745 | Consumer Defensive |